Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04739982 · ClinicalTrials.gov registry record · NA
A Lead-in Study Evaluating Efficacy of GuessWhat Mobile App Therapy for Children With Autism
A NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 541
- Enrollment target
- 1
- Study location
NCT04739982: Completed NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.
NCT04739982 is a NA study of Autism Spectrum Disorder and Autism that has completed, run by Stanford University. The registered enrollment target is 541 participants, above the 133-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (307% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04739982, a NA study of Autism Spectrum Disorder and Autism, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 541 participants
- Enrollment target
- 1
- Study location
Study Summary
The following study aims to assess the efficacy, safety data, and best outcome measurements of the mobile game platform, GuessWhat, in delivering behavioral therapy to children with Autism Spectrum Disorder (ASD). GuessWhat is a mobile application (available for free for iOS and Android) which contains a suite of games: pro-social charades, emotion guessing, and quiz. Participant families will use their personal smartphones to download the app and play it with their child according to a predetermined regimen.
Primary Outcome
Vineland Adaptive Behavior Scales, 3rd edition (VABS-3) Socialization subscale of the Parent/Caregiver Comprehensive form will be administered online to the parents. Scores from the socialization domain of the VABS-III reflects one's functioning in social situations. The socialization subscale is up to 112 items depending on age and development, where raw scores are converted to IQ-type standard scores with mean 100 and standard deviation of 15, and factor in age equivalents, growth scale values
Conditions Studied
Interventions
- DEVICE GuessWhat Mobile App
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2021-07-07 |
| Est. Completion | 2023-07-15 |
| Phase | NA |
What the finished NCT04739982 record still lists
NCT04739982 is an interventional study that assigns participants to a tested intervention. The registered 541 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (307% higher).
The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which GuessWhat Mobile App is the first listed.
NCT04739982 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04739982 about?
NCT04739982 is a clinical study titled "A Lead-in Study Evaluating Efficacy of GuessWhat Mobile App Therapy for Children With Autism". The following study aims to assess the efficacy, safety data, and best outcome measurements of the mobile game platform, GuessWhat, in delivering behavioral therapy to children with Autism Spectrum Disorder (ASD). GuessWhat is a mobile application (available for free for iOS and Android) which conta...
What is the current status of trial NCT04739982?
This trial is currently completed. It is a NA study. The enrollment target is 541 participants. The study started on 2021-07-07. Estimated completion is 2023-07-15.
What conditions does trial NCT04739982 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism.
What interventions are being tested in trial NCT04739982?
The interventions under investigation include: GuessWhat Mobile App (DEVICE).
Who is sponsoring clinical trial NCT04739982?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04739982 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04739982's enrollment target sits among peer trials
541 9th of 224 higher than 216 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04929223 · 542 participants · Phase 1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- NCT05584670 · 542 participants · Phase 1
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI